Background: Nevirapine, a component of antiretroviral therapy (ART) in resource-limited settings is known for auto-induction of metabolism, and thus is prescribed at half therapeutic dose until day14 ('lead-in period'), and then escalated to full dose. However, young children have higher clearance rates, suggesting that dosing strategy based on adult studies may not be appropriate in children. We aimed to determine plasma nevirapine concentrations achieved during the first month among children initiated on nevirapine-containing ART Methods & Materials: ART-naïve HIV-infected children, initiating ART were included in this prospective study. Plasma nevirapine trough levels were analyzed in duplicate (with additional 10% repeats for quality control) by high performance liquid chromatography (HPLC) (lowest detection limit 0.062 g/ml) at days 7, 14 (lead-in period) and 28 (full dose) after ART initiation. Baseline transmitted drug resistance genotyping, serial CD4 count and viral load was done.
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Results: Among 28 children aged 2-12 years initiated on nevirapine-based ART between 2013-2014, six were excluded due to drug toxicity, and two were transferred out within first month. Among 20 children included in the study, 19 reported >95% adherence at all study visits. Transmitted drug resistance was seen in 5(10%) children (V90I, K103N, K101E, E138G, Y188L, M41L, L210W, T215Y). Median trough nevirapine concentration was 4.83g/ml (IQR 3.48-6.06) at day 7 of ART initiation, 3.35g/ml (IQR 2.06-7.91) at day 14 (lead-in period), and 7.97g/ml (IQR 5.55-10.66) on day 28 (p= 0.018). During the lead-in period 40% (8/20; 15% at day 7, 35% at day 14) of children failed to achieve therapeutic levels of >3 g/ml, while after dose escalation, only 5% (1/20) had low therapeutic levels. Low trough nevirapine levels was not significantly associated with age, viral load, CD4 count or transmitted drug resistance.
Conclusion: Our results showed significantly lower therapeutic concentrations of nevirapine during the lead-in period in young children initiating nevirapine-based ART in India. Given nevirapine's low genetic barrier, sub-therapeutic levels during the early high viremic period can lead to later drug resistance development and treatment failure. Long-term drug resistance studies among viral quasispecies can determine the true effect of early subtherapeutic concentrations (WHO, 2010) . Sub Saharan Africa is the region most affected with 67% of all people living with HIV worldwide and 91% of all new infections among children. In South Africa, the mother-to-child HIV transmission (MTCT) rate is under 4% at 4 to 8 weeks after birth since the implementation of the most recent national PMTCT programme. The PMTCT programme in South Africa has gained rapid momentum in training and practice.
Methods & Materials: This study was conducted in Gauteng province of South Africa. We sought to investigate the level of knowledge and whether the doctors and nurses working at Odi were practicing the current PMTCT program. A descriptive cross sectional survey using self-administered questionnaires was used. The study population consisted of 31 doctors and 180 nurses.
Results: There were 102 participants. There were 12 (12%) doctors and 90 (88%) professional nurses. There 9 (9%) males and 93 (91%) females. Thirty four participants (33%) underwent further training beyond their undergraduate qualification. The mean knowledge percentage per participant was 60.8% and 77% for the mean practice percentage per participant. In the knowledge questions, the question on the first step (HIV counseling and testing) scored an average 93.1% (highest) by participants and the doses of drugs used in the PMTCT guidelines scored 17.7% (lowest) by participants. In the practice questions, the score for each question ranged from 71% to 82%.
Conclusion: Nurses and doctors working at Odi Hospital know that HIV counseling and testing is important and must be done on all mothers; however they were unsure of the dosages of the drugs used for PMTCT. More than two thirds of the doctors and nurses reported to be practicing the PMTCT guidelines, however as their knowledge was inadequate, their enthusiasm is lost by actually not knowing the correct drugs and dosages for the PMTCT which impacts on the correct PMTCT practice.
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